(CIDRAP News) The Centers for Disease Control and Prevention (CDC) gives a detailed report on its ongoing investigation of the current anthrax attack in today's issue of Morbidity and Mortality Weekly Report. The report includes a detailed treatment protocol for inhalational anthrax related to the current attack, calling for use of either ciprofloxacin or doxycycline plus one or two other antimicrobials.
(CIDRAP New) Officials from the Mayo Clinic and Roche Molecular Biochemicals today announced the development of a DNA test that they say can accurately detect anthrax bacteria in human and environmental samples in less than an hour, far faster than currently available tests. They said they will begin making the test available free to public health laboratories this week to help combat the current spate of anthrax attacks.
(CIDRAP News) Donald A. Henderson, MD, public health expert and director of the successful campaign to eradicate smallpox in the 1970s, has been appointed to coordinate the national response to public health emergencies. Tommy G. Thompson, secretary of the Department of Health and Human Services (HHS), named Henderson last week as director of the newly created Office of Public Health Preparedness.
(CIDRAP News) Teams of specialists at the Centers for Disease Control and Prevention have been vaccinated against smallpox and are training to respond to any intentional release of the smallpox virus, the CDC has announced.
Nov 8 (CIDRAP News) The Centers for Disease Control and Prevention (CDC) is working on model legislation to equip states to cope with public health emergencies, and the current draft is now available on the Internet, according to a recent announcement by Secretary of Health and Human Services Tommy G. Thompson.
Nov 12 (CIDRAP News) Improved survival among victims of the recent anthrax attacks, as compared with past anthrax cases, is probably a result of better antibiotic regimens, early recognition and treatment, and improved supportive care, among other factors, according to Centers for Disease Control and Prevention (CDC) officials.
Nov 16, 2001 (CIDRAP News) In the current investigation of anthrax cases, the Centers for Disease Control and Prevention (CDC) will try to determine if some parts of the country have a normal background level of anthrax spores that poses no threat to humans and, if so, what that level is, CDC officials said today.
(CIDRAP News) If smallpox reappears in the United States, health authorities will strive to trace and vaccinate everyone who has had contact with infected or exposed persons but probably will not mount any mass vaccination campaigns, according to a draft plan released Monday by the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) About 19% of more than 3,000 postal workers who took ciprofloxacin to prevent anthrax from the recent bioterrorist attacks reported having "severe" gastrointestinal side effects, but only 2% sought medical attention for them, according to the Centers for Disease Control and Prevention (CDC). Officials described the findings as being in line with other reports on ciprofloxacin.
(CIDRAP News) Large-scale quarantine of potentially exposed people is not likely to be the optimal strategy for containing a disease outbreak resulting from bioterrorism in most circumstances, according to public health experts writing in today's issue of the Journal of the American Medical Association.